glp-1 drugs uses Medications: Everything You Need to Know The GLP-1 Agonists and Obesity:
Description
Percent change in weight from baseline to week 72 Primary outcome: Results Among participants with obesity but without diabetes, treatment with tirzepatide was superior to treatment with semaglutide with respect to reduction in body weight and waist circumference at week 72
There was a slightly higher rate of gallbladder disorders in the semaglutide group (2.8% vs
Dipeptidyl peptidase inhibitor therapy in type 2 diabetes: Control of the incretin axis and regulation of postprandial glucose and lipid metabolism
Diabetes: new mechanism for insulin resistance
